Evidence map›Paper›PMID 35633418›Full record

ArticleMolecular biology reports2022

Downregulation of glob1 mitigates human tau mediated neurotoxicity by restricting heterochromatin loss and elevating the autophagic response in drosophila.

Nisha, Surajit Sarkar

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

NishaDepartment of Genetics, University of Delhi South Campus, Benito Juarez Road, New Delhi, 110021, India.
Surajit SarkarDepartment of Genetics, University of Delhi South Campus, Benito Juarez Road, New Delhi, 110021, India. sarkar@south.du.ac.in.ORCID http://orcid.org/0000-0001-6861-2271
University of Delhi · IN

Funding

Department of Biotechnology, Government of India BT/010/IYBA/2017/02
6 · The paper itself

Abstract

backgroundHuman neuronal tauopathies are typically characterized by the accumulation of hyperphosphorylated tau in the forms of paired helical filaments and/or neurofibrillary tangles in the brain neurons. Tau-mediated heterochromatin loss and subsequent global transcriptional upsurge have been demonstrated as one of the key factors that promotes tau toxicity. We have reported earlier that expression of human tau-transgene in Drosophila induces the expression of glob1, and its restored level restricts tau etiology by regulating tau hyperphosphorylation and ROS generation via GSK-3β/p-Akt and Nrf2-keap1-ARE pathways, respectively. In view of this noted capability of glob1 in regulation of oxidative stress, and involvement of ROS in chromatin remodeling; we investigate if downregulation of glob1 restores tau-mediated heterochromatin loss in order to alleviate neurotoxicity. METHODS AND

resultsThe tau

conclusionsOur study unfolds a novel aspect of the multitasking globin protein in restricting the pathogenesis of neuronal tauopathies. Interestingly, due to notable similarities between Drosophila glob1 and human globin gene(s), our findings may be helpful in developing novel therapeutic approaches against tauopathies.

Indexed as

Drosophila ProteinsTauopathiesAnimalsDisease Models, AnimalDown-RegulationDrosophilaDrosophila melanogasterGlobinsGlycogen Synthase Kinase 3 betaHeterochromatinHumansKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2PhosphorylationReactive Oxygen SpeciesDrosophila ProteinsGlobinsGlycogen Synthase Kinase 3 betaHeterochromatinKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Reactive Oxygen SpeciesDrosophilaglob1Histone modificationsNeurodegenerationTauopathies

Identifiers

PMID35633418
OpenAlexW4281665416

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.